Valuations

TRADERSPRO PRESENTS Retire In 18 Months With $2.4 Million?

37 year old trader uses this “unconventional” strategy to turn $10K into $2.4 million in only 18 months. Another trader turned $5K into $15 million and still another turned $30K into $80 million. Click here to discover their millionaire maker strategy. - 

Starting Soon - Please Join Us 

Entertainment
Media
Stock Picks
Valuations

Why One Analyst Says This Stock Is Too Cheap To Ignore Now

“Enough is enough,” the analyst wrote. This stock is “too cheap on any reasonable sum-of-the-parts valuation.”

Read More
Fibonacci Retracement
Fundamental Analysis
InvestivDaily
Tariffs
Tech Industry
Tech Stocks
Technical Analysis
Technology
Trade War
Valuations
Value Investing

XLNX’s price movement has diverged from the Semiconductor industry in a big way

It’s no big surprise to say that trade tensions are continuing to play out at the forefront of investor’s famously short attention span. So far this week, rumors that the eagerly anticipated “Phase One” of a trade deal between the U.S. and China might not happen before the end of the year seem to have […]

Read More
Economy
Fundamental Analysis
Growth Stocks
HeathCare
InvestivDaily
Medical Devices
Tariffs
Technical Analysis
Trade War
US Economy
Valuations
Value Investing

EW looks like an interesting growth stock – but don’t make the mistake of thinking it’s a bargain

I’m wrapping up my run through the Healthcare Equipment industry by looking at a stock that, like just about the entire rest of the industry, is at the extreme high end of a very long-term upward trend. Part of the reason that this industry has drawn my attention this week is because of the extended […]

Read More
Fibonacci Retracement
Fundamental Analysis
HeathCare
InvestivDaily
Medical Devices
Risk
Technical Analysis
Valuations
Value Investing

Despite being near an all-time high, SYK might still offer an interesting value

This week, I’ve been turning my focus to Healthcare stocks, most particularly to the Healthcare Equipment industry of that sector. The most-established stocks in the industry all seem to be at or very near to all-time high levels – something that I believe is driven by broad fundamental strength among most of these companies as […]

Read More
Consumer Discretionary
Discretionary
Fibonacci Retracement
Fundamental Analysis
Inventions
Tariffs
Technical Analysis
Valuations
Value Traps

IRBT is down nearly -45% since April – is that an opportunity, or a warning?

The Consumer Discretionary sector has been one of the highest-performing sectors in the market year-to-date; as the broad market has pushed to new all-time highs, so has this sector, increasing about 24% year to date and more than 4% in the last month, as measured by the S&P 500 Consumer Discretionary Sector SPDR ETF (XLY). […]

Read More
Biopharmaceuticals
Fibonacci Retracement
Fundamental Analysis
InvestivDaily
Pharmaceuticals
Technical Analysis
Valuations
Value Investing

LLY is down almost 15% from all-time high. Is it a good time to buy?

In the last week I’ve been focusing my attention in this space on a few of the biggest, most established names in the pharmaceutical space. It’s an industry that I think is becoming more interesting under current market conditions, as some of these names remain significantly off of multi-year, or even all-time highs even as […]

Read More
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
InvestivDaily
Pharmaceuticals
Risk
Technical Analysis
Valuations
Value Investing
Volatility

Big value proposition, plus a blockbuster pending merger: is BMY a smart trade right now?

If you’ve followed my highlights in this space, you’ve seen me write on a number of occasions about how my value-focused investing approach tends to make me think in defensive terms under current market conditions. As the major indices are driving to new all-time highs, a lot of growth-oriented folks think that sounds pretty silly; […]

Read More
China
Consumer Staples
Federal Reserve
Fibonacci Retracement
Fundamental Analysis
InvestivDaily
Tariffs
Valuations

PPC could be an interesting proxy for trade peace – but not without fundamental risk

It seems inevitable right now that no matter what other element may be at play in the market, the conversation right now inevitably turns back to trade and tariffs. The big news in the market yesterday initially was the latest Fed meeting, and its decision to keep interest rates steady for the time being. The […]

Read More

There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Companys software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.

FREE TRADING WEBINAR - TRADERSPRO PRESENTS: Starting With Only $10,000 Retire With $2.4 Million? Click Here Now

Join Us Now
X